PreveCeutical Medical Inc (18H) — Cash Flow-to-Debt Ratio
PreveCeutical Medical Inc (18H) has a Cash Flow-to-Debt Ratio of -0.07x as of September 2025, meaning its operating cash flow of €-520.46K could theoretically repay 0% of its total liabilities (€7.85 Million) in one year. See PreveCeutical Medical Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
PreveCeutical Medical Inc Cash Flow-to-Debt Ratio (2016–2024)
Historical debt coverage capacity for PreveCeutical Medical Inc across 9 annual periods. Also explore PreveCeutical Medical Inc (18H) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for PreveCeutical Medical Inc (2016–2024)
Year-by-year debt coverage analysis for PreveCeutical Medical Inc. For market capitalisation and broader financial context, see PreveCeutical Medical Inc (18H) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.06x | €-426.69K | €6.86 Million | ▼ -24.8% |
| 2023 | -0.05x | €-296.97K | €5.96 Million | ▲ +46.7% |
| 2022 | -0.09x | €-450.99K | €4.82 Million | ▲ +6.5% |
| 2021 | -0.10x | €-426.39K | €4.27 Million | ▼ -704.6% |
| 2020 | 0.02x | €64.59K | €3.91 Million | ▲ +108.9% |
| 2019 | -0.19x | €-993.94K | €5.34 Million | ▲ +89.7% |
| 2018 | -1.81x | €-7.57 Million | €4.19 Million | ▼ -23.9% |
| 2017 | -1.46x | €-4.30 Million | €2.94 Million | ▲ +44.1% |
| 2016 | -2.61x | €-1.32 Million | €503.24K | — |